Search Within

Sandra Pierina D'Angelo

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (136)
  2. Journal Article (104)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (252)
  2. Hematologic Malignancies, Division of (252)
  3. Sarcoma Service (252)
  4. Solid Tumor Oncology Division (252)
  5. GSK Faculty (101)
  6. Tow Center for Developmental Oncology (TCDO) (88)

More Groups

People
  1. William Tap (104)
  2. Mark Dickson (83)
  3. Mrinal Gounder (72)
  4. Mary Keohan (70)
  5. Ping Chi (58)
  6. Cristina Antonescu (53)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Journal for ImmunoTherapy of Cancer (22)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (103)
  2. Biomed Central Ltd (24)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (252)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Van Tine, B. A.; Attia, S.; Blay, J. Y.; Strauss, S. J.; Morales, C. M. V.; Razak, A. R. A.; Van Winkle, E.; Trivedi, T.; Biswas, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Safety and efficacy of letetresgene autoleucel (lete-cel; GSK3377794) in advanced myxoid/round cell liposarcoma (MRCLS) following high lymphodepletion (Cohort 2): Interim analysis
    Meeting Abstract

    D'Angelo, S. P.; Druta, M.; Van Tine, B. A.; Liebner, D. A.; Schuetze, S.; Hasan, A. N.; Holmes, A. P.; Huff, A.; Kapoor, G. S.; Zajic, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    D'Angelo, S. P.; Robinson, S. I.; Lam, J.; Adams, B. J.; Freddo, J. L.; Theuer, C. P.; Maki, R. G.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after > 5 years of follow-up
    Journal Article

    D'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Case report: Response to regional melphalan via limb infusion and systemic PD1 blockade in recurrent myxofibrosarcoma: A report of 2 cases
    Journal Article

    Bartlett, E. K.; D’Angelo, S. P.; Kelly, C. M.; Siegelbaum, R. H.; Fisher, C.; Antonescu, C. R.; Ariyan, C. E.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast
    Journal Article

    Kuba, M. G.; Xu, B.; D’Angelo, S. P.; Rosenbaum, E.; Plitas, G.; Ross, D. S.; Brogi, E.; Antonescu, C. R.
    Histopathology (2021)

    Fulltext@MSK | Save
  • Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer
    Meeting Abstract

    Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S.; Ladle, B. H.; Noujaim, J.; He, K.; Liebner, D.; Sacher, A. G.; Haanen, J. B. A. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab, and envafolimab in combination with ipilimumab, in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    D'Angelo, S.; Robinson, S.; Lam, J.; Adams, B.; Freddo, J.; Theuer, C. P.; Maki, R.
    Cancer Research (2021)

    Fulltext@MSK | Save